Thierry Bogaert
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Thierry_Bogaert".

Thierry Bogaert is a Belgian scientist and businessman. He is one of the cofounders of the Belgian biotech company DevGen.

Education

He graduated from the University of Ghent (Ghent, Belgium) and received an MSc degree form the University of Manitoba (Winnipeg, Canada). He obtained a PhD at the Laboratory of Molecular Biology, Medical Research Council, (Cambridge, United Kingdom).

Career

As an academic, he held faculty positions at the Laboratory of Molecular Biology of the Medical Research Council (MRC-LMB) in Cambridge and the Medical Faculty of the University of Ghent. His research interest was about Drosophila melanogaster integrins^[1][2] and the Caenorhabditis elegans UNC gene (uncoordinated phenotype) ^[3]

In 1997, he founded DevGen and became its Chief Executive Officer.

References

1. ^ Bogaert T, Brown N, Wilcox M, The Drosophila PS2 antigen is an invertebrate integrin that, like the fibronectin receptor, becomes localized to muscle attachments, Cell. 1987 Dec 24;51(6):929-40
2. ^ Leptin M, Bogaert T, Lehmann R, Wilcox M, The function of PS integrins during Drosophila embryogenesis, Cell. 1989 Feb 10;56(3):401-8
3. ^ Stringham E, Pujol N, Vandekerckhove J, Bogaert T, unc-53 controls longitudinal migration in C. elegans, Development. 2002 Jul;129(14):3367-79

Sources

• Gents biotechbedrijf laat insecten zelfmoord plegen
• Thierry Bogaert

This Belgian biographical article is a stub. You can help Wikipedia by expanding it.

This European business-related biographical article is a stub. You can help Wikipedia by expanding it.